Related Experiment Video
Updated: Aug 20, 2026

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
Quantitative structure-activity relationship studies on some series of calcium channel blockers
S P Gupta1, Anupriya Veerman, Priyanka Bagaria
1Department of Chemistry, Birla Institute of Technology and Science, Pilani, India. spg@bits-pilani.ac.in
Abstract:
A quantitative structure-activity relationship (QSAR) study has been made on four different series of dihydropyrimidine analogs that mimic the most widely studied class of calcium channel blockers (CCBs)-the 1,4-dihydropyridine (DHP) class. The results show that almost all those characteristics that are essential for the activity of 1,4-DHPs are also essential for the activity of dihydropyrimidine analogs. The important characterstics indicated by the present study for dihydropyrimidine analogs are conformation of the molecule, the relative orientation of the aryl ring with respect to the pyrimidine ring, and some substituents capable of forming the hydrogen bonds with the receptor but less bulky in nature, and high molar refractivity of the molecule.
More Related Videos
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

